Chronic Kidney Disease Improvement In Research and Treatment Act Reintroduced in Congress



The Chronic Kidney Disease Improvement in Research and Treatment Act (H.R. 5027) was reintroduced on July 27, 2023 in the U.S. House of Representatives.

The proposed legislation would bolster initiatives for preventing Chronic Kidney Disease (CKD) by
guaranteeing appropriate reimbursement for quality care. It would enhance patient access to cutting-edge drugs, technology, and advancements in kidney care. The proposed legislation includes provisions to enhance CKD screening through Medicare’s annual wellness benefit, provide education resources in dialysis facilities, encourage innovation by requiring long-term payment pathways for new medical advancements, and address dialysis infrastructure and workforce challenges. Additionally, it would widen patient options and coverage by ensuring access to Medigap policies for those with kidney failure.

Click Here to read the entire August 2023 Healthcare Law Update now!

For more information, contact:
John D. Fanburg, Chair | 973.403.3107 |
Edward Hilzenrath | 973.403.3114 |
Vanessa Coleman | 973.364.5208 |

*This is intended to provide general information, not legal advice. Please contact the authors if you need specific advice.

Related Practices:   Healthcare Law

Related Industry:   Healthcare